Quince Therapeutics, Inc. (NASDAQ:QNCX) Sees Significant Decline in Short Interest
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) was the recipient of a large decline in short interest in February. As of February 27th, there was short interest totaling 8,298,192 shares, a decline of 19.7% from the February 12th total of 10,338,418 shares. Based on an average daily volume of 41,372,336 shares, the short-interest ratio […]
15 Mar 10:40 · The Cerbat Gem